Synapse - Find an Expert

6564 Results

Peri-transplant vitamin and micronutrient status in allogeneic hematopoietic cell transplantation

Meeting Abstract

Rodich, L.; Adintori, P. A.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Gossman, Z.; Shike, M.; Barker, J. N.; Jakubowski, A. A.; Kernan, N. A.; more...
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save

Post-transplant Cyclophosphamide (PTCy) is associated with superior gvhd-free, relapse-free survival (GRFS) in HLA-mismatched unrelated donor (MMUD) hematopoietic cell transplantation

Meeting Abstract

Jimenez, A. M. J; Perales, M. A.; Devlin, S. M.; Brown, S.; Lekakis, L. J.; Sauter, C. S.; Pereira, D.; Wang, T. P.; Ponce, D. M.; Beitinjaneh, A.; more...
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save

Allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase inhibitor era

Meeting Abstract

Vaughn, J. L.; Devlin, S. M.; Berman, E.; Mauro, M. J.; Papadopoulos, E. B.; Perales, M. A.; Tallman, M.; Giralt, S. A.; Gyurkocza, B.
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save

Extended letermovir prophylaxis is highly effective cytomegalovirus (CMV) infection prevention in adult cord blood transplantation (CBT) recipients & does not prevent emergence of CMV-specific donor-derived immunity

Meeting Abstract

Politikos, I.; Lau, C.; Devlin, S. M.; Naputo, K.; Quach, S.; Chinapen, S.; Lin, A.; Papadopoulos, E. B.; Perales, M. A.; Shah, G.; more...
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save

Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma

Meeting Abstract

Dahi, P. B.; Geyer, A.; Kenny, S.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Lahoud, O. B.; Matasar, M. J.; Moskowitz, C. H.; Perales, M. A.; more...
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save

Double unit cord blood transplantation compares favorably to T-cell depleted matched adult donor transplantation for the treatment of acute leukemia due to a robust protection against relapse

Meeting Abstract

Politikos, I.; Flynn, J.; Devlin, S. M.; Fingrut, W.; Maloy, M. A.; Naputo, K.; Chinapen, S.; Rodriguez, N. T.; Quach, S.; Dominguez, Y.; more...
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save

Treatment response and clinical outcomes of neuroendocrine neoplasms (NENs) treated with immune checkpoint inhibitors (ICIs): A single institution experience

Meeting Abstract

Hauser, H.; Le, T.; Chou, J. F.; Heffernan, O.; DeMore, A.; Gonen, S.; Capanu, M.; Reidy-Lagunes, D.; Raj, N.
Pancreas (2022)

Fulltext@MSK | Save

Randomized blinded study comparing injection site pain from octreotide long-acting-release (LAR) versus lanreotide during the treatment of well- differentiated neuroendocrine tumors (WDNETs)